Device Trial Radar · NCT07941830
AI-Based Anatomy Recognition in Minimally Invasive Kidney Surgery
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
1,700
Planned (sponsor's estimate)
Start
Nov 15, 2026
Primary completion
Dec 25, 2026
Study completion Dec 30, 2026
Sponsor
- Lead sponsor
- Chinese PLA General HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Tongji Hospital; Tianjin Medical University Second Hospital; Peking University First Hospital; West China Hospital; First Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; RenJi Hospital; The Second Affiliated Hospital of Xi 'an Jiaotong University
- First posted
- Nov 17, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to evaluate whether an artificial intelligence (AI) based software system can assist surgeons in identifying key anatomical structures during minimally invasive upper urinary tract surgery. During these procedures, surgeons operate while viewing images from laparoscopic endoscope. Key anatomical structures, such as the kidney, renal artery and vein, ureter, renal pelvis, inferior vena cava, and left reproductive vein, as well as surgical targets such as tumors, may sometimes be difficult to distinguish because of bleeding, surgical smoke, tissue movement, changes in tissue appearance, or obstruction by surgical instruments. The study team has developed an AI-based image recognition system that analyzes surgical video in real time and identifies and outlines relevant anatomical structures on the screen during surgery. The study has two main goals (primary endpoints): 1. To evaluate how accurately the AI system can identify and delineate key anatomical structures in surgical videos collected from different hospitals, surgeons, surgical procedures, and imaging systems. 2. To evaluate the real-time performance and technical reliability of the AI system in the operating room, including processing latency, frame rate, system failure rate, and the proportion of time during surgery in which AI-generated results are successfully displayed. The study will include adults aged 18 years or older who undergo one of five types of minimally invasive upper urinary tract surgery: partial nephrectomy, radical nephrectomy, radical nephroureterectomy, inferior vena cava tumor thrombectomy, or pyeloplasty. The study will be conducted at 11 hospitals in China. In the first phase, surgical videos recorded between 2015 and 2025 will be used to develop, validate, and test the AI system. In the second phase, approximately 100 patients will be prospectively enrolled from internal centers, and the AI-generated anatomical recognition results will be displayed on a monitor during surgery. Overall, approximately 1,600 retrospective surgical cases and 100 prospective cases are planned for inclusion. The AI system is designed solely as an assistive tool for anatomical recognition. It does not make clinical decisions, provide autonomous surgical instructions, or control any surgical equipment. Surgeons remain fully responsible for all clinical and surgical decisions, and the AI display can be turned off at any time. All participants will receive standard clinical care. Participation in the study will not involve any additional medications, surgical procedures, or blood tests. Identifying personal information will be removed from the surgical videos and clinical data used for the study, and all study data will be stored securely in accordance with applicable data protection requirements. As secondary objectives, the study will compare the performance of the AI system with that of surgeons with different levels of surgical experience using a set of challenging surgical images or video frames. The study will also evaluate surgeons' experience with the system, including its usability, clarity of display, and whether the AI-generated information interferes with or affects the surgical workflow.
Conditions
- Kidney (Renal Cell) Cancer
- Ureteropelvic Junction Obstruction
- Upper Urinary Tract Carcinoma
Interventions
AI-based intra-operative anatomical perception systemDevice
An AI-based software system that analyzes the live surgical video feed during minimally invasive upper urinary tract surgery and performs real-time identification and delineation of key anatomical structures and surgical targets, including the kidney, renal artery and vein, ureter, renal pelvis, inferior vena cava, tumors, and adjacent organs. The AI-generated results are overlaid on a surgical monitor to provide intraoperative visual assistance to the surgeon. The system functions solely as an assistive visualization tool; it does not make clinical decisions, provide autonomous surgical guidance, or control any surgical equipment. All surgical decisions remain under the responsibility of the operating surgeon, and the AI display can be turned off at any time.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dice coefficientTime frame: From enrollment to the end of surgery at 3 days
- Intersection over Union, IoUTime frame: From enrollment to the end of surgery at 3 days
- PrecisionTime frame: From enrollment to the end of surgery at 3 days
5 more outcomes with a free account
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.